Sociedad Americana de Hirudoterapia

Successful pediatric heart transplantation with bivalirudin use in a cyanotic single ventricle patient with an intracorporeal continuous flow ventricular assist device and heparin-induced thrombocytopenia

Case report published in Indian Journal of Thoracic and Cardiovascular Surgery (2025)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Case reportEnsayos clínicosDesarrollo de fármacosSainathan S, Mulinari L · Indian Journal of Thoracic and Cardiovascular Surgery, 2025

Abstract

We describe a case of profound coagulopathy during orthotopic heart transplantation in a cyanotic single ventricle pediatric patient with an intracorporeal continuous flow ventricular assist device performed on bivalirudin for heparin-induced thrombocytopenia. This was successfully managed with central veno-arterial extracorporeal membrane oxygenation and hemofiltration as an adjunct to treat bivalirudin-induced coagulopathy due to lack of a reversal agent for bivalirudin.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeCase ReportsJournal Article

Resumen

Successful orthotopic heart transplant in a cyanotic single ventricle pediatric patient on continuous-flow VAD with HIT, with bivalirudin anticoagulation managed using V-A ECMO and hemofiltration as adjuncts due to lack of bivalirudin reversal agent.

Por qué esto importa para la hirudoterapia

This case report describes a cyanotic single-ventricle pediatric patient with an intracorporeal continuous-flow ventricular assist device and heparin-induced thrombocytopenia who underwent orthotopic heart transplantation anticoagulated with bivalirudin. Profound coagulopathy developed and was managed with central veno-arterial extracorporeal membrane oxygenation and hemofiltration, partly because bivalirudin lacks a reversal agent. The abstract does not mention hirudin, leeches, leech therapy, or the leech secretome, so no direct connection to hirudotherapy can be made from this source. Relevance to ASH's domain, if any, is not established by the abstract. The evidence is limited to a single case report with minimal detail on outcomes beyond acute management.

Citación

Successful pediatric heart transplantation with bivalirudin use in a cyanotic single ventricle patient with an intracorporeal continuous flow ventricular assist device and heparin-induced thrombocytopenia.

Sainathan S, Mulinari L · Indian Journal of Thoracic and Cardiovascular Surgery, 2025

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.